The Lancet: Major progress against hepatitis C by 2030 is possible, but will need vast improvements in screening, prevention and treatment

(The Lancet) A comprehensive package of prevention, screening, and treatment interventions could avert 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths globally by 2030 -- equal to an 80 percent reduction in incidence and a 60 percent reduction in deaths compared with 2015, according to the first study to model hepatitis C interventions globally published in The Lancet.

from EurekAlert! - Social and Behavioral Science http://bit.ly/2B85v97